191 related articles for article (PubMed ID: 31940085)
1. Use of antidepressants and mood stabilizers in persons with first-episode schizophrenia.
Puranen A; Koponen M; Tanskanen A; Tiihonen J; Taipale H
Eur J Clin Pharmacol; 2020 May; 76(5):711-718. PubMed ID: 31940085
[TBL] [Abstract][Full Text] [Related]
2. Comparative Effectiveness of Adjunctive Psychotropic Medications in Patients With Schizophrenia.
Stroup TS; Gerhard T; Crystal S; Huang C; Tan Z; Wall MM; Mathai C; Olfson M
JAMA Psychiatry; 2019 May; 76(5):508-515. PubMed ID: 30785609
[TBL] [Abstract][Full Text] [Related]
3. Antipsychotic polypharmacy and augmentation strategies prior to clozapine initiation: a historical cohort study of 310 adults with treatment-resistant schizophrenic disorders.
Thompson JV; Clark JM; Legge SE; Kadra G; Downs J; Walters JT; Hamshere ML; Hayes RD; Taylor D; MacCabe JH
J Psychopharmacol; 2016 May; 30(5):436-43. PubMed ID: 26905920
[TBL] [Abstract][Full Text] [Related]
4. Real-world effectiveness of mood stabilizer use in schizophrenia.
Puranen A; Koponen M; Lähteenvuo M; Tanskanen A; Tiihonen J; Taipale H
Acta Psychiatr Scand; 2023 Mar; 147(3):257-266. PubMed ID: 36065482
[TBL] [Abstract][Full Text] [Related]
5. Use of mood stabilizers for hospitalized psychotic and bipolar disorder patients.
Ventriglio A; Vincenti A; Centorrino F; Talamo A; Fitzmaurice G; Baldessarini RJ
Int Clin Psychopharmacol; 2011 Mar; 26(2):88-95. PubMed ID: 21030870
[TBL] [Abstract][Full Text] [Related]
6. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
7. Use of psychiatric medications in schizophrenia and other psychoses in a general population sample.
Nykänen S; Puska V; Tolonen JP; Salo H; Isohanni M; Koponen H; Pirkola S; Penttilä M; Haapea M; Moilanen J; Miettunen J; Jääskeläinen E
Psychiatry Res; 2016 Jan; 235():160-8. PubMed ID: 26652841
[TBL] [Abstract][Full Text] [Related]
8. Racial differences in the use of adjunctive psychotropic medications for patients with schizophrenia.
Mallinger JB; Lamberti SJ
J Ment Health Policy Econ; 2007 Mar; 10(1):15-22. PubMed ID: 17417044
[TBL] [Abstract][Full Text] [Related]
9. Association of Pharmacological Treatments and Hospitalization and Death in Individuals With Amphetamine Use Disorders in a Swedish Nationwide Cohort of 13 965 Patients.
Hartikainen M; Taipale H; Tanskanen A; Mittendorfer-Rutz E; Lähteenvuo M; Tiihonen J
JAMA Psychiatry; 2023 Jan; 80(1):31-39. PubMed ID: 36383348
[TBL] [Abstract][Full Text] [Related]
10. Overactive, aggressive, disruptive and agitated behavior associated with the use of psychotropic medications in schizophrenia.
Strømme MF; Bartz-Johannesen C; Kroken RA; Mehlum L; Johnsen E
Schizophr Res; 2022 Oct; 248():35-41. PubMed ID: 35933742
[TBL] [Abstract][Full Text] [Related]
11. The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia.
Chen H; Kennedy WK; Dorfman JH; Fincham JE; Reeves J; Martin BC
Curr Med Res Opin; 2007 Jun; 23(6):1351-65. PubMed ID: 17559734
[TBL] [Abstract][Full Text] [Related]
12. Polypharmacy with antipsychotics, antidepressants, or benzodiazepines and mortality in schizophrenia.
Tiihonen J; Suokas JT; Suvisaari JM; Haukka J; Korhonen P
Arch Gen Psychiatry; 2012 May; 69(5):476-83. PubMed ID: 22566579
[TBL] [Abstract][Full Text] [Related]
13. Use of Benzodiazepines and Antipsychotic Drugs Are Inversely Associated With Acute Readmission Risk in Schizophrenia.
Strømme MF; Mellesdal LS; Bartz-Johannesen CA; Kroken RA; Krogenes ML; Mehlum L; Johnsen E
J Clin Psychopharmacol; 2022 Jan-Feb 01; 42(1):37-42. PubMed ID: 34928559
[TBL] [Abstract][Full Text] [Related]
14. Effects of polypharmacy on outcome in patients with schizophrenia in routine psychiatric treatment.
Längle G; Steinert T; Weiser P; Schepp W; Jaeger S; Pfiffner C; Frasch K; Eschweiler GW; Messer T; Croissant D; Becker T; Kilian R
Acta Psychiatr Scand; 2012 May; 125(5):372-81. PubMed ID: 22321029
[TBL] [Abstract][Full Text] [Related]
15. Medication and aggressiveness in real-world schizophrenia. Results from the FACE-SZ dataset.
Fond G; Boyer L; Favez M; Brunel L; Aouizerate B; Berna F; Capdevielle D; Chereau I; Dorey JM; Dubertret C; Dubreucq ; Faget C; Gabayet F; Laouamri H; Lancon C; Le Strat Y; Misdrahi D; Rey R; Passerieux C; Schandrin A; Schurhoff F; Tronche AM; Urbach M; Vidalhet P; Llorca PM; Pelissolo A;
Psychopharmacology (Berl); 2016 Feb; 233(4):571-8. PubMed ID: 26630993
[TBL] [Abstract][Full Text] [Related]
16. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
Munch G; Godart N
Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
[TBL] [Abstract][Full Text] [Related]
17. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
18. Lifetime use of psychiatric medications and cognition at 43years of age in schizophrenia in the Northern Finland Birth Cohort 1966.
Hulkko AP; Murray GK; Moilanen J; Haapea M; Rannikko I; Jones PB; Barnett JH; Huhtaniska S; Isohanni MK; Koponen H; Jääskeläinen E; Miettunen J
Eur Psychiatry; 2017 Sep; 45():50-58. PubMed ID: 28728095
[TBL] [Abstract][Full Text] [Related]
19. Psychotropic drugs use and psychotropic polypharmacy among persons with Alzheimer's disease.
Orsel K; Taipale H; Tolppanen AM; Koponen M; Tanskanen A; Tiihonen J; Gardarsdottir H; Hartikainen S
Eur Neuropsychopharmacol; 2018 Nov; 28(11):1260-1269. PubMed ID: 30153953
[TBL] [Abstract][Full Text] [Related]
20. Treatment of schizoaffective disorder and schizophrenia with mood symptoms.
Levinson DF; Umapathy C; Musthaq M
Am J Psychiatry; 1999 Aug; 156(8):1138-48. PubMed ID: 10450252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]